jason hunt
jason hunt
Associate Professor Otolaryngology
Verified email at
Cited by
Cited by
NCCN guidelines insights: thyroid carcinoma, version 2.2018
RI Haddad, C Nasr, L Bischoff, NL Busaidy, D Byrd, G Callender, ...
Journal of the National Comprehensive Cancer Network 16 (12), 1429-1440, 2018
Thyroid carcinoma, version 2.2014
RM Tuttle, RI Haddad, DW Ball, D Byrd, P Dickson, QY Duh, H Ehya, ...
Journal of the National Comprehensive Cancer Network 12 (12), 1671-1680, 2014
Anaplastic thyroid carcinoma, version 2.2015
RI Haddad, WM Lydiatt, DW Ball, NL Busaidy, D Byrd, G Callender, ...
Journal of the National Comprehensive Cancer Network 13 (9), 1140-1150, 2015
Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma ofá…
RS Rodrigues, FA Bozza, PE Christian, JM Hoffman, RI Butterfield, ...
Journal of Nuclear Medicine 50 (8), 1205-1213, 2009
Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort
M Hashibe, J Hunt, M Wei, S Buys, L Gren, YCA Lee
Head & neck 35 (7), 914-922, 2013
Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families
KW Jasperson, W Kohlmann, A Gammon, H Slack, L Buchmann, J Hunt, ...
Familial cancer 13, 257-265, 2014
A systematic review and meta-analysis of the diagnostic accuracy of frozen section for parotid gland lesions
RL Schmidt, JP Hunt, BJ Hall, AR Wilson, LJ Layfield
American journal of clinical pathology 136 (5), 729-738, 2011
Psychosocial distress is prevalent in head and neck cancer patients
L Buchmann, J Conlee, J Hunt, J Agarwal, S White
The Laryngoscope 123 (6), 1424-1429, 2013
BRAF V600E does not predict aggressive features of pediatric papillary thyroid carcinoma
DJ Givens, LO Buchmann, AM Agarwal, JF Grimmer, JP Hunt
The Laryngoscope 124 (9), E389-E393, 2014
Comparing human and mouse salivary glands: A practice guide for salivary researchers
CL Maruyama, MM Monroe, JP Hunt, L Buchmann, OJ Baker
Oral diseases 25 (2), 403-415, 2019
Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology
RI Haddad, L Bischoff, D Ball, V Bernet, E Blomain, NL Busaidy, ...
Journal of the National Comprehensive Cancer Network 20 (8), 925-951, 2022
IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck
ME Montejo, DC Shrieve, BG Bentz, JP Hunt, LO Buchman, N Agarwal, ...
International Journal of Radiation Oncology* Biology* Physics 81 (5), e845-e852, 2011
Robotic surgery of the infratemporal fossa utilizing novel suprahyoid port
RR McCool, FM Warren, RH Wiggins III, JP Hunt
The Laryngoscope 120 (9), 1738-1743, 2010
Psychosocial distress in patients with thyroid cancer
L Buchmann, S Ashby, RB Cannon, JP Hunt
Otolaryngology--Head and Neck Surgery 152 (4), 644-649, 2015
An analysis of factors predicting lateral cervical nodal metastases in papillary carcinoma of the thyroid
JP Hunt, LO Buchmann, L Wang, D Abraham
Archives of otolaryngology–head & neck surgery 137 (11), 1141-1145, 2011
Treatment‐related determinants of survival in early‐stage (T1–2N0M0) oral cavity cancer: A population‐based study
JC Sowder, RB Cannon, LO Buchmann, JP Hunt, Y Hitchcock, S Lloyd, ...
Head & neck 39 (5), 876-880, 2017
Primary lesions of the root of the tongue
WS Fang, RH Wiggins III, A Illner, BE Hamilton, GL Hedlund, JP Hunt, ...
Radiographics 31 (7), 1907-1922, 2011
Association of the Patient Protection and Affordable Care Act with insurance coverage for head and neck cancer in the SEER database
RB Cannon, HM Shepherd, H McCrary, PS Carpenter, LO Buchmann, ...
JAMA Otolaryngology–Head & Neck Surgery 144 (11), 1052-1057, 2018
Association of celecoxib use with decreased opioid requirements after head and neck cancer surgery with free tissue reconstruction
PS Carpenter, HM Shepherd, H McCrary, V Torrecillas, A Kull, JP Hunt, ...
JAMA Otolaryngology–Head & Neck Surgery 144 (11), 988-994, 2018
Phase 1b/2, open label, multicenter, study of the combination of SD-101 and pembrolizumab in patients with advanced melanoma who are na´ve to anti-PD-1 therapy.
MM Milhem, GV Long, CJ Hoimes, A Amin, CD Lao, RM Conry, J Hunt, ...
Journal of clinical oncology 37 (15_suppl), 9534-9534, 2019
The system can't perform the operation now. Try again later.
Articles 1–20